Heart disease is not a single malfunction but a cascade of overlapping failures in blood vessels, heart muscle, electrical signaling, and metabolism. The term covers everything from clogged coronary arteries to inherited muscle defects and rhythm disturbances, and the mechanisms behind each form are distinct even though they often feed into one another. Understanding how these processes unfold at a tissue and cellular level helps explain why heart disease manifests so differently from person to person and why treatments that work for one type can be useless, or even harmful, for another.
How Atherosclerosis Begins in the Artery Wall
The popular image of atherosclerosis is a pipe slowly filling with grease. The reality is more like an ongoing wound-healing response that never resolves. It starts at the endothelium, the single-cell lining of every artery. In straight, high-flow stretches, blood pushes steadily against endothelial cells, and that mechanical force actually keeps the lining healthy. Flow-exposed endothelial cells release nitric oxide, a molecule that relaxes the vessel wall and, critically, makes the surface less sticky to passing immune cells. One early study found that prior exposure to normal flow reduced the ability of monocytes to cling to the endothelium by about half, largely through nitric-oxide release.1Circulation. Exposure to Shear Stress Alters Endothelial Adhesiveness
The trouble happens at bends, branches, and bifurcations where blood slows down, eddies, or reverses direction. Under these low-shear-stress conditions, endothelial cells become activated in ways that invite trouble. They upregulate adhesion molecules on their surface, essentially putting out molecular “welcome mats” for circulating white blood cells. Research has shown that low shear stress activates inflammatory signaling inside endothelial cells, boosting the expression of molecules like VCAM-1 that grab passing monocytes.2PubMed. Low shear stress regulates monocyte adhesion to oxidized lipid-induced endothelial cells via an IkappaBalpha dependent pathway Separately, low shear stress can trigger endothelial cell death and further monocyte adhesion through upregulation of the adhesion protein PECAM-1.3PubMed Central. Low shear stress induces endothelial cell apoptosis and monocyte adhesion by upregulating PECAM‑1 expression This is why atherosclerotic plaques cluster in predictable spots around arterial branch points rather than appearing uniformly throughout the vascular system.
From Fatty Streaks to Dangerous Plaques
Once monocytes have burrowed into the artery wall, they mature into macrophages and begin scavenging oxidized LDL cholesterol that has seeped in and become trapped. Macrophages have scavenger receptors that readily take up this oxidized LDL. When a macrophage engulfs enough of it, the oxidized lipid components activate internal signaling through a receptor called PPARγ, altering gene expression in ways that promote further lipid uptake.4Cell. Oxidized Low-Density Lipoprotein Activates the Transcriptional Factor PPARγ through Scavenger Receptor-Mediated Release of HODE Ligands The macrophage becomes bloated with cholesterol esters and transforms into a foam cell. Accumulations of foam cells are what makes up the fatty streak, the earliest visible marker of atherosclerosis that can appear even in teenagers.
The process escalates as more oxidized LDL accumulates and more macrophages arrive. These immune cells release inflammatory signals that recruit still more white blood cells, creating a self-perpetuating loop. The interaction between oxidized LDL and macrophages is considered one of the most important steps in plaque growth, directly driving lipid accumulation and the transition from a mild fatty streak into a true atherosclerotic lesion.5PubMed Central. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process
The real danger comes not from how large a plaque grows but from how structurally vulnerable it becomes. Each plaque has a fibrous cap separating its lipid-rich core from the bloodstream. When that cap is thin, heavily inflamed, and depleted of the collagen that gives it tensile strength, the plaque is classified as “vulnerable.” Enzymes called metalloproteinases, released by inflammatory cells within the plaque, degrade collagen and weaken the cap.6PubMed Central. Metalloproteinases and vulnerable atherosclerotic plaques Higher levels of metalloproteinase activity, especially when driven by ongoing inflammation, can contribute to the cap rupturing entirely.7Physiological Reviews. Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture When that happens, the plaque’s interior is suddenly exposed to flowing blood. A clot forms on the ruptured surface within seconds, and that clot can partially or completely block the artery. If the artery feeds the heart, you get a heart attack. If it feeds the brain, a stroke.
What Happens During a Heart Attack at the Cellular Level
When a coronary artery is blocked and heart muscle loses its blood supply, the affected cells switch from their normal oxygen-dependent metabolism to an emergency anaerobic mode that produces far less energy. The cell’s stores of high-energy phosphate compounds deplete rapidly. Once those stores are exhausted and the cell can no longer generate enough energy even from glycolysis, the damage becomes irreversible.8PubMed Central. Lethal myocardial ischemic injury Cell membranes break down, calcium floods in uncontrollably, and the muscle fibers die.
Paradoxically, restoring blood flow after a blockage causes additional harm. When oxygen-rich blood re-enters starved tissue, a burst of reactive oxygen species is generated inside mitochondria. These reactive molecules, combined with the rapid normalization of the cell’s internal pH, trigger a damaging chain reaction. A structure called the mitochondrial permeability transition pore opens wide, collapsing the cell’s energy-generating machinery and leading to further cell death.9PubMed Central. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species Studies on isolated heart cells have confirmed that reactive oxygen species formation is the upstream trigger: blocking those reactive molecules with antioxidants prevented the pore opening, the energy collapse, and the cell death that follows reperfusion.10American Journal of Physiology-Heart and Circulatory Physiology. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion
This phenomenon, called reperfusion injury, is a major reason why even successful emergency procedures to reopen a blocked artery do not fully prevent damage. The heart muscle that survives is often a patchwork of healthy tissue and scar, and that patchwork creates its own set of problems.
How the Heart Remodels After Injury
After a heart attack kills a region of muscle, the surviving tissue is forced to work harder to compensate. That extra workload triggers a process called ventricular remodeling: the heart chambers change shape, the walls thicken unevenly, and the muscle fibers reorganize. Initially, some of this is adaptive. Over time, it tends to become destructive.
At the molecular level, the surviving heart cells enlarge through signaling pathways that sense increased mechanical load. One of the best-studied routes involves a protein complex called calcineurin and its downstream partner NFAT. In animal models of pressure overload and in post-heart-attack heart failure, calcineurin/NFAT signaling ramps up in a sustained way, driving pathological thickening of the heart wall.11PubMed. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy This particular pathway interacts with other stress-sensing signaling branches, and the cross-talk between them helps determine whether the heart’s response stays compensatory or tips into disease.12Cardiovascular Research. Calcineurin–NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs
Alongside the muscle cells enlarging, the heart lays down excessive scar tissue, or fibrosis. Fibroblasts, the cells responsible for producing structural protein in connective tissue, are pushed into an activated state by a growth factor called TGF-β. Once activated, fibroblasts transform into myofibroblasts that aggressively produce collagen and other matrix proteins.13PubMed Central. Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players TGF-β has been identified as the dominant signal overriding other cues in pushing this transformation.14PubMed Central. TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts The resulting fibrosis stiffens the heart wall, impairs its ability to fill and pump, and creates electrical dead zones that set the stage for dangerous rhythm disturbances.
Why a Weakened Heart Fails to Pump Properly
Heart failure is the downstream consequence of many of these processes. Whether the initial insult was a heart attack, chronic high blood pressure, or a genetic muscle defect, the endpoint converges on a common set of cellular dysfunctions. One of the most consistent findings in failing heart cells is a breakdown in calcium handling. Every heartbeat depends on a precisely timed surge and removal of calcium inside each muscle cell. A protein pump called SERCA2a is responsible for pulling calcium back into storage between beats, allowing the muscle to relax and refill. In advanced heart failure, SERCA2a activity drops, and that single deficit drives both the inability to contract forcefully and the inability to relax properly between beats.15US Cardiology. SERCA2a Gene Transfer Therapy for Heart Failure
Not all heart failure involves a weakened pump. Roughly half of all heart failure patients have a preserved ejection fraction, meaning the heart squeezes out a normal percentage of blood with each beat but is too stiff to fill properly in between. In this form, the giant spring-like protein titin plays a central role. Titin acts as a molecular spring within each muscle cell, and when its chemical state is altered by inflammation or oxidative stress, it becomes stiffer, making the entire chamber less compliant. Metabolic conditions like obesity and diabetes are especially prone to driving this kind of stiffness through systemic inflammation that reaches the heart’s small blood vessels and, ultimately, the muscle fibers themselves.16PubMed Central. The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
Scar Tissue and Abnormal Heart Rhythms
After a heart attack, the dead muscle is replaced by scar tissue. But that scar is rarely a clean patch. It typically contains strands of surviving muscle fibers running through it in disorganized patterns. Electrical impulses that would normally travel smoothly through healthy tissue are forced to zigzag through these surviving strands, slowing down and sometimes looping back on themselves. This creates the conditions for a dangerous type of arrhythmia called ventricular tachycardia, where a self-perpetuating electrical circuit fires rapidly and can prevent the heart from pumping effectively.17PubMed Central. Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar The conduction slowing is worsened by reduced gap junctions, the protein channels that connect one heart cell to the next electrically.18PubMed Central. Ventricular scars and ventricular tachycardia
Arrhythmias can also arise from the calcium-handling problems described earlier. In chronic atrial fibrillation, for instance, the sarcoplasmic reticulum inside atrial muscle cells leaks calcium at inappropriate times. That leaking calcium gets traded out of the cell by a sodium-calcium exchanger, generating small electrical currents that can trigger extra heartbeats. These so-called delayed afterdepolarizations occur more frequently in patients with chronic atrial fibrillation, and the coupling between elevated internal calcium and membrane voltage disturbances is stronger than in healthy hearts.19Circulation. Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation
When the Small Vessels Are the Problem
Not all heart disease involves the large coronary arteries you see on an angiogram. A growing number of patients, particularly women, present with chest pain and signs of ischemia but have coronary arteries that appear wide open. The problem is in the microcirculation: tiny arterioles and capillaries that regulate blood flow deep within the heart muscle. This condition, known by the acronym INOCA (ischemia with non-obstructive coronary arteries), involves dysfunction in these small vessels. Testing can distinguish between endothelium-independent microvascular dysfunction, measured by indices of flow resistance during pharmacological stress, and endothelium-dependent dysfunction, where vessels fail to dilate or even constrict in response to acetylcholine.20PubMed Central. INOCA/ANOCA: Mechanisms and novel treatments
Microvascular disease has historically been under-recognized because standard cardiac catheterization focuses on the large vessels. When the angiogram looks “clean,” both patient and physician may assume nothing is wrong. The mechanisms behind microvascular dysfunction overlap with many of the processes described above: inflammation, oxidative stress, and metabolic disruption all contribute to impaired small-vessel function, making it an area where heart disease pathophysiology intersects with systemic health in ways that are easy to miss.
Epicardial Fat and Gut-Derived Metabolites
The heart sits within a layer of fat called epicardial adipose tissue. Unlike the fat under your skin, epicardial fat is in direct contact with the coronary arteries and the heart muscle, with no fascial barrier between them. In patients at high cardiovascular risk, this fat produces elevated levels of inflammatory signaling molecules, including IL-6, TNF-α, and others.21Circulation. Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators Because these molecules are secreted right next to the coronary arteries and myocardium, they can influence plaque development and heart muscle function through local paracrine effects, not just through the bloodstream.22PubMed. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease
Another metabolic player gaining attention is trimethylamine N-oxide, or TMAO, a compound produced when gut bacteria break down nutrients like choline and carnitine found in red meat, eggs, and certain fish. Elevated TMAO levels in the blood have been linked to accelerated atherosclerosis. The compound appears to promote vascular inflammation while simultaneously reducing reverse cholesterol transport, the process by which cholesterol is ferried away from artery walls back to the liver for disposal.23PubMed. Trimethylamine N-oxide in cardiovascular disease: Pathophysiology and the potential role of statins The implication is that the composition of your gut microbiome can influence your risk of coronary disease through a pathway that is entirely separate from traditional cholesterol levels.
The Hormonal and Vascular Stiffness Connection
Arterial stiffness increases with age, and it is both a consequence and a cause of cardiovascular damage. The renin-angiotensin-aldosterone system (RAAS), the hormonal circuit best known for regulating blood pressure, contributes to stiffness through altered collagen turnover and increased fibrosis within vessel walls. Many of the complications seen with excess angiotensin II or aldosterone, including left ventricular thickening, endothelial dysfunction, and organ damage, are also associated with arterial stiffness, suggesting that reduced arterial compliance is one mechanism through which an overactive RAAS does its harm.24PubMed. Arterial stiffness and the renin-angiotensin-aldosterone system This overlap is part of the reason RAAS-blocking medications like ACE inhibitors have benefits that extend well beyond simply lowering blood pressure.
In women, the hormonal story has an additional layer. Estrogen supports endothelial function through receptor-mediated signaling that promotes vasodilation. After menopause, the loss of estrogen triggers a rapid decline in endothelial vasodilator function that is independent of chronological aging itself. Estrogen receptor expression in blood vessels drops with both acute and prolonged estrogen deficiency, accelerating the rise in cardiovascular risk factors that women experience after menopause.25American Journal of Physiology-Heart and Circulatory Physiology. Aging women and their endothelium: probing the relative role of estrogen on vasodilator function This explains the well-known pattern in which women’s heart disease risk lags behind men’s until midlife and then converges rapidly.
Genetic Mutations and Inherited Heart Muscle Disease
Not all heart disease builds up over decades from lifestyle and aging. Hypertrophic cardiomyopathy, the most common inherited heart disease, is frequently caused by mutations in genes encoding proteins within the sarcomere, the fundamental contractile unit of heart muscle. Mutations in the gene MYH7, which encodes part of the molecular motor that generates force, have been shown to reduce the force-generating capacity of sarcomeres. Studies on heart tissue from patients with these mutations found that the lower force output was partly due to the cells being hypertrophied with reduced density of contractile fibers, but that the sarcomeres themselves were intrinsically weaker, particularly at the calcium concentrations seen during normal contraction.26Cardiovascular Research. Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy The heart’s response to this primary weakness is to thicken, producing the characteristic asymmetric hypertrophy. But that compensatory thickening can itself cause obstruction, arrhythmias, and sudden cardiac death, particularly in young athletes.
Clonal Hematopoiesis and Diabetic Metabolism
Two relatively new areas of research illustrate how heart disease pathophysiology extends well beyond the heart and arteries themselves. Clonal hematopoiesis of indeterminate potential, or CHIP, is a condition in which a stem cell in the bone marrow acquires a genetic mutation and produces a disproportionately large fraction of the circulating blood cells. This becomes increasingly common with age. Certain CHIP driver mutations, particularly in genes like TET2 and JAK2, appear to amplify atherosclerotic events, likely by producing white blood cells with a heightened inflammatory profile. Interestingly, mutations in DNMT3a, another common CHIP driver, appear less atherogenic, highlighting that the specific mutation matters.27JCI Insight. Clonal hematopoiesis and atherosclerosis
In diabetes, the heart’s metabolism shifts in ways that compound the structural problems. Healthy heart muscle is an omnivore, burning a mix of fatty acids, glucose, and other fuels. In diabetes, the heart becomes heavily reliant on fatty acid oxidation, and this fuel preference itself is damaging. It lowers cardiac efficiency, worsens the heart’s energy balance, and actively suppresses glucose oxidation, creating a metabolic inflexibility that makes the diabetic heart more vulnerable to ischemia and more prone to the stiff, poorly relaxing form of heart failure.28PubMed Central. The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity This metabolic dimension helps explain why diabetes so dramatically increases the risk of heart failure even when coronary arteries are not severely blocked.